Ensuring continued access to essential inhaled respiratory medications: a call to action from the Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) group. [PDF]
Eur Respir JHurst JR +11 more
europepmc +1 more source
P195 Plume characteristics of fluticasone propionate/formoterol pMDI compared with fluticasone propionate/salmeterol pMDI: Abstract P195 Table 1. [PDF]
Thorax, 2013 B Johal, S Murphy, J Marshall
openaire +1 more source
A Prospective Study of Inhaled Therapy Prescribing, Pressurised Metered-Dose Inhaler (pMDI) Technique Assessment, and Inhaler Concordance Monitoring Among Hospitalised Adult Patients With Airways Disease. [PDF]
CureusLai L +5 more
europepmc +1 more source
Prescribing trends and environmental impact of prescribed inhaled medicines in Australia. [PDF]
Chron Respir DisLam SWL +4 more
europepmc +1 more source
[Pharmacological prescription: inhalers and antimicrobials]. [PDF]
Aten PrimariaBarrio Díez I, Rodríguez Ferré AM.
europepmc +1 more source
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care. [PDF]
NPJ Prim Care Respir MedAgusti A +4 more
europepmc +1 more source
An expert opinion on the management of pediatric patients with wheezing and mild asthma: translating 2025 GINA strategy report into clinical practice in Italy. [PDF]
Ital J PediatrSantamaria F +6 more
europepmc +1 more source
Comparing 6-Year Carbon Footprint Between GINA Track 1 and 2 Asthma Management for Adults: A Real-World Primary Care Report from Singapore to Advocate for Policy Change in Inhaler Procurement. [PDF]
J Prim Care Community HealthTan NC, Ng DX, Leow MQH, Koh YLE.
europepmc +1 more source
Focus on pMDI and VHC; Past, Present, Future! [PDF]
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2014 openaire +1 more source
As-needed inhaled corticosteroids in asthma: from evidence to implementation. [PDF]
Curr Opin Pulm MedMerrell E, Khurana S.
europepmc +1 more source